INR 29.0
(-0.82%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 291.17 Million INR | -44.89% |
2022 | 373.95 Million INR | -7.57% |
2021 | 404.58 Million INR | -29.32% |
2020 | 572.44 Million INR | 1.93% |
2019 | 561.6 Million INR | 16.55% |
2018 | 481.83 Million INR | 1.34% |
2017 | 475.45 Million INR | 75.61% |
2016 | 270.74 Million INR | 0.0% |
2015 | - INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 53.53 Million INR | -21.43% |
2023 Q1 | 88.5 Million INR | 137.45% |
2023 FY | 206.09 Million INR | -44.89% |
2023 Q2 | 94.31 Million INR | 6.56% |
2023 Q3 | 41.25 Million INR | -56.26% |
2023 Q4 | 68.12 Million INR | 65.15% |
2022 Q3 | 117.2 Million INR | 4.72% |
2022 Q1 | 107.54 Million INR | 31.49% |
2022 FY | 373.95 Million INR | -7.57% |
2022 Q4 | 37.27 Million INR | -68.2% |
2022 Q2 | 111.92 Million INR | 4.07% |
2021 Q1 | 132.09 Million INR | 10.45% |
2021 FY | 404.58 Million INR | -29.32% |
2021 Q4 | 81.79 Million INR | -1.87% |
2021 Q3 | 83.35 Million INR | -35.46% |
2021 Q2 | 129.14 Million INR | -2.24% |
2020 Q2 | 148.94 Million INR | 10.92% |
2020 FY | 572.44 Million INR | 1.93% |
2020 Q4 | 119.59 Million INR | -26.9% |
2020 Q1 | 134.29 Million INR | -22.63% |
2020 Q3 | 163.6 Million INR | 9.84% |
2019 FY | 561.6 Million INR | 16.55% |
2019 Q3 | 135.32 Million INR | 2.23% |
2019 Q2 | 132.37 Million INR | 13.76% |
2019 Q1 | 116.37 Million INR | -6.49% |
2019 Q4 | 173.56 Million INR | 28.25% |
2018 Q4 | 124.44 Million INR | -0.41% |
2018 Q3 | 124.95 Million INR | 2.86% |
2018 Q2 | 121.48 Million INR | 7.13% |
2018 Q1 | 113.39 Million INR | -18.49% |
2018 FY | 481.83 Million INR | 1.34% |
2017 FY | 475.45 Million INR | 75.61% |
2017 Q2 | 148.75 Million INR | 67.25% |
2017 Q4 | 139.12 Million INR | 23.7% |
2017 Q3 | 112.47 Million INR | -24.39% |
2017 Q1 | 88.94 Million INR | 0.0% |
2016 Q1 | 64.93 Million INR | 0.0% |
2016 FY | 270.74 Million INR | 0.0% |
2015 FY | - INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Ajanta Pharma Limited | 30.46 Billion INR | 99.044% |
Amrutanjan Health Care Limited | 1.09 Billion INR | 73.505% |
Sigachi Industries Limited | 579.88 Million INR | 49.788% |
Bal Pharma Limited | 389.89 Million INR | 25.319% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 86.292% |
Medico Remedies Limited | 161.84 Million INR | -79.91% |
Venus Remedies Limited | 1.91 Billion INR | 84.805% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 90.536% |
Alpa Laboratories Limited | 156.14 Million INR | -86.474% |
Nectar Lifesciences Limited | 625.55 Million INR | 53.453% |
Shilpa Medicare Limited | 2.18 Billion INR | 86.647% |
Aarti Drugs Limited | 1.16 Billion INR | 75.06% |
Lupin Limited | 95.67 Billion INR | 99.696% |
Aurobindo Pharma Limited | 39.23 Billion INR | 99.258% |
Zydus Lifesciences Limited | 43.17 Billion INR | 99.326% |
Windlas Biotech Limited | 1 Billion INR | 71.071% |
Suven Life Sciences Limited | 109.75 Million INR | -165.307% |
Eris Lifesciences Limited | 4.94 Billion INR | 94.109% |
Valiant Laboratories Limited | 36.28 Million INR | -702.375% |
J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 96.541% |
Solara Active Pharma Sciences Limited | 4.57 Billion INR | 93.642% |
Ipca Laboratories Limited | 13.91 Billion INR | 97.907% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 79.484% |
Achyut Healthcare Limited | 1.6 Million INR | -17996.582% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.811% |
Bajaj HealthCare Limited | 985.34 Million INR | 70.45% |
RPG Life Sciences Limited | 1.63 Billion INR | 82.197% |
Mankind Pharma Limited | 23.15 Billion INR | 98.742% |
Laurus Labs Limited | 3.01 Billion INR | 90.329% |
Piramal Pharma Limited | 19.91 Billion INR | 98.538% |
Syncom Formulations (India) Limited | 942.39 Million INR | 69.103% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 98.641% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 98.165% |
Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 99.569% |
Unichem Laboratories Limited | 6.72 Billion INR | 95.671% |
Sequent Scientific Limited | 2.9 Billion INR | 89.966% |
Novartis India Limited | 470.1 Million INR | 38.061% |
Wanbury Limited | 1.16 Billion INR | 74.919% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 79.243% |
Wockhardt Limited | 6.4 Billion INR | 95.45% |
Themis Medicare Limited | 782.85 Million INR | 62.806% |
Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | 62.352% |
Jubilant Pharmova Limited | 14.45 Billion INR | 97.986% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 97.499% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.696% |
Divi's Laboratories Limited | 14.17 Billion INR | 97.945% |
NATCO Pharma Limited | 10.05 Billion INR | 97.105% |
Gufic Biosciences Limited | 1.07 Billion INR | 72.982% |
IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | 73.501% |
Ind-Swift Limited | 946.56 Million INR | 69.239% |
Procter & Gamble Health Limited | 2.99 Billion INR | 90.279% |
FDC Limited | 5.34 Billion INR | 94.556% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -530.848% |
Granules India Limited | 7.18 Billion INR | 95.946% |
Medicamen Biotech Limited | 335.16 Million INR | 13.126% |
Alkem Laboratories Limited | 32.83 Billion INR | 99.113% |
AstraZeneca Pharma India Limited | 2.6 Billion INR | 88.803% |
Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -1696.295% |
Brooks Laboratories Limited | 51.18 Million INR | -468.921% |
Megasoft Limited | 49.52 Million INR | -487.898% |
ZIM Laboratories Limited | 1.01 Billion INR | 71.258% |
Strides Pharma Science Limited | 9.16 Billion INR | 96.822% |
Neuland Laboratories Limited | 2.92 Billion INR | 90.061% |
Morepen Laboratories Limited | 1.98 Billion INR | 85.349% |
Hikal Limited | 2.48 Billion INR | 88.289% |
Indoco Remedies Limited | 4.74 Billion INR | 93.868% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 90.529% |
Kilitch Drugs (India) Limited | 412.42 Million INR | 29.4% |
Mangalam Drugs & Organics Limited | 676.14 Million INR | 56.936% |
Hester Biosciences Limited | 908.84 Million INR | 67.962% |